BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37883754)

  • 21. Use of a high b-value for diffusion weighted imaging of peritumoral regions to differentiate high-grade gliomas and solitary metastases.
    Han C; Huang S; Guo J; Zhuang X; Han H
    J Magn Reson Imaging; 2015 Jul; 42(1):80-6. PubMed ID: 25223489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of 2D BLADE turbo gradient- and spin-echo diffusion-weighted imaging in the quantitative diagnosis of recurrent temporal bone cholesteatoma.
    Lin M; Geng Y; Sha Y; Zhang Z; Zhou K
    BMC Med Imaging; 2022 Jul; 22(1):132. PubMed ID: 35883055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral schistosomiasis: diffusion-weighted imaging helps to differentiate from brain glioma and metastasis.
    Huang J; Luo J; Peng J; Yang T; Zheng H; Mao C
    Acta Radiol; 2017 Nov; 58(11):1371-1377. PubMed ID: 28090792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
    Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
    BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiating between non-functioning pituitary macroadenomas and sellar meningiomas using ADC.
    Zhang J; Zhao Z; Dong L; Han T; Zhang G; Cao Y; Zhou J
    Endocr Connect; 2020 Dec; 9(12):1233-1239. PubMed ID: 33112805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas.
    Yang Y; Yang Y; Wu X; Pan Y; Zhou D; Zhang H; Chen Y; Zhao J; Mo Z; Huang B
    J Neurooncol; 2020 Jan; 146(2):363-371. PubMed ID: 31902040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative grading of supratentorial nonenhancing gliomas by high b-value diffusion-weighted 3 T magnetic resonance imaging.
    Han H; Han C; Wu X; Zhong S; Zhuang X; Tan G; Wu H
    J Neurooncol; 2017 May; 133(1):147-154. PubMed ID: 28439776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
    Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
    Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apparent diffusion coefficient in the evaluation of cerebral gliomas malignancy.
    Ignjatović J; Stojanov D; Zivković V; Ljubisavljević S; Stojanović N; Stefanović I; Benedeto-Stojanović D; Ignjatović N; Petrović S; Aracki-Trenkić A; Radovanović Z; Lazović L
    Vojnosanit Pregl; 2015 Oct; 72(10):870-5. PubMed ID: 26665552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The utility of diffusion MRI with quantitative ADC measurements for differentiating high-grade from low-grade cerebral gliomas: Evidence from a meta-analysis.
    Zhang L; Min Z; Tang M; Chen S; Lei X; Zhang X
    J Neurol Sci; 2017 Feb; 373():9-15. PubMed ID: 28131237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of apparent diffusion coefficient values derived from diffusion-weighted imaging for assessing different sized metastatic lymph nodes in cervical cancers.
    Zhang A; Song J; Ma Z; Chen T
    Acta Radiol; 2020 Jun; 61(6):848-855. PubMed ID: 31615267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
    Feng A; Yuan P; Huang T; Li L; Lyu J
    Acad Radiol; 2022 Sep; 29(9):1320-1331. PubMed ID: 34896001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.
    Arevalo-Perez J; Peck KK; Young RJ; Holodny AI; Karimi S; Lyo JK
    J Neuroimaging; 2015; 25(5):792-8. PubMed ID: 25867683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of diffusion-weighted imaging in preoperative evaluation and prediction of postoperative supplementary therapy for patients with cervical cancer.
    Liu L; Wang S; Yu T; Bai H; Liu J; Wang D; Luo Y
    Ann Transl Med; 2022 Jan; 10(2):120. PubMed ID: 35282103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of diffusion-weighted magnetic resonance imaging for local and skull base recurrence of nasopharyngeal carcinoma after radiotherapy.
    Wang C; Liu L; Lai S; Su D; Liu Y; Jin G; Zhu X; Luo N
    Medicine (Baltimore); 2018 Aug; 97(34):e11929. PubMed ID: 30142809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.
    McDonald ES; Romanoff J; Rahbar H; Kitsch AE; Harvey SM; Whisenant JG; Yankeelov TE; Moy L; DeMartini WB; Dogan BE; Yang WT; Wang LC; Joe BN; Wilmes LJ; Hylton NM; Oh KY; Tudorica LA; Neal CH; Malyarenko DI; Comstock CE; Schnall MD; Chenevert TL; Partridge SC
    Radiology; 2021 Jan; 298(1):60-70. PubMed ID: 33201788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic role of apparent diffusion coefficient combined with intratumoral susceptibility signals in differentiating high-grade gliomas from brain metastases.
    Bozdağ M; Er A; Çinkooğlu A; Ekmekçi S
    Neuroradiol J; 2021 Jun; 34(3):169-179. PubMed ID: 33307971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An initial study on the predictive value using multiple MRI characteristics for Ki-67 labeling index in glioma.
    Du N; Shu W; Li K; Deng Y; Xu X; Ye Y; Tang F; Mao R; Lin G; Li S; Fang X
    J Transl Med; 2023 Feb; 21(1):119. PubMed ID: 36774480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of T2-weighted MRI contrast ratio combined with DWI in evaluating the pathological grade of solid lung adenocarcinoma.
    Dang S; Han D; Duan H; Jiang Y; Aihemaiti A; Yu N; Yu Y; Duan X
    Clin Radiol; 2024 Apr; 79(4):279-286. PubMed ID: 38216369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival prediction based on qualitative MRI diffusion signature in patients with recurrent high grade glioma treated with bevacizumab.
    Goyal P; Tenenbaum M; Gupta S; Kochar PS; Bhatt AA; Mangla M; Kumar Y; Mangla R
    Quant Imaging Med Surg; 2018 Apr; 8(3):268-279. PubMed ID: 29774180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.